The safety and efficacy of immune checkpoint inhibitor rechallenge after immune-related adverse events in stage IV NSCLC patients. Meeting Abstract

cited authors

  • Guo, Mengni; Vanderwalde, Ari M.; Yu, Xinhua; Vidal, Gregory A.; Tian, Gary G.

Publication Date

  • June 1, 2022

webpage

published in

category

volume

  • 40

issue

  • 16